A Top-Notch Treatment Algorithm for Localized Non-Small Cell Lung Cancer
By Oncology Brothers - Last Updated: March 15, 2023The Oncology Brothers are joined by nationally renowned researcher and thoracic oncologist Charu Aggarwal, MD, MPH, of Penn Center for Precision Medicine, to discuss a treatment algorithm for localized non-small cell lung cancer (NSCLC). The trio detail the best treatment approaches for stage I-III NSCLC – stages where therapy is administered with curative intent.
Advertisement
Advertisement
Related Posts
The study investigators concluded that ivonescimab “might represent another treatment option in the first-line setting."
Dr. Liu unpacks key questions in the field, and the research that could address them.
Certain surgical procedures and margins were more frequent in patients who had suture-line recurrences.
The long-term follow-up data shows that PFS remains unreached in the subgroup of Asian patients in the CROWN study.
Researchers evaluated if there was a link between pretreatment systemic immune inflammation index levels and outcomes.
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.